trending Market Intelligence /marketintelligence/en/news-insights/trending/Cz7K_AkO9zY2FzIT4jVi_w2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Sanofi nominates director to Regeneron Pharmaceuticals board

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Sanofi nominates director to Regeneron Pharmaceuticals board

Regeneron Pharmaceuticals Inc. added Tony Coles to its board.

The director was nominated by Sanofi, which owns 21.9% of the company, according to S&P Capital IQ data.

Coles is the chairman and CEO of Yumanity Therapeutics.